Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori;Eficacia de una triple terapia con un inhibidor de la bomba de protones, levofloxacino y amoxicilina, como primer tratamiento, en la erradicación de Helicobacter pylori

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 6, 2009, Pages 395-402

  Castro Fernández, Manuel ^a   Lamas, E ^a   Perez Pastor A ^a   Pabon M ^a   Aparcero, R ^a   Vargas Romero, J ^a   Larraona, J L ^a   Romero Gomez M ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Helicobacter pylori; Levofloxacin; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; LEVOFLOXACIN; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METALLIC TASTE; MYALGIA; NAUSEA AND VOMITING; PATIENT COMPLIANCE; SEIZURE; TASTE DISORDER; THRUSH; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST;

EID: 70349897850     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082009000600004     Document Type: Article

References (30)

1. Monés J, Gisbert JP, Borda F, Domínguez-Muñoz E, y Grupo Conferencia Española de Consenso sobre Helicobacter pylori. Indications, diagnostic test and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference. Rev Esp Enferm Dig 2005; 97: 348-374
2. Gisbert JP, Calvet X, Gomollón F, Monés J, y Grupo Conferencia Española de Consenso sobre Helicobacter pylori. Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la II Conferencia Española de Consenso. Med Clin (Barc.) 2005; 125: 301-316
3. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al., for The European Helicobacter Study Group (EHSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781
4. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am 2006; 35: 229-247
5. Graham DY, Lu H, Yamaoka. Therapy for Helicobacter pylori infection can be improved. Drugs 2008; 68: 725-736
6. Cavallaro LG, Egan B, O'Morain C, Di Mario F. Treatment of Helicobacter pylori infection. Helicobacter 2006; 11 (Supl. 1): 36-39
7. Rokkas T, Sechopoulos P, Robotis I, Margantinis G, Pistiolas D. Cumulative H. pylori eradication rates in clinical practice by adopting first-and second-line regimens proposed by the Maastricht III Consensus and a third-line empirical regimen. Am J Gastroenterol 2008; 103: 1-5.
8. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007; 133: 985-1001.
9. Egan BJ, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2008; 13(Supl. 1): 35-40.
10. Cammarota G, Cianci R, Cannizzaro O, Cuoco L, Pirozzi G, Gasbarrini A, et al. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmaco Ther 2000;14: 1339-1343 (Pubitemid 30802387)
11. Antos D, Schneider-Brachert W, Bästlein E, Hänel C, Haferland C, Buchner M, et al. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with know antimicrobial sensitivity. Helicobacter 2006; 11: 39-45.
12. Marzio L, Coraggio D, Capodicasa S, Grossi L, Cappello G. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole. Helicobacter 2006; 11: 237-242. (Pubitemid 44051349)
13. Nista E, Candelli M, Zocco MA, Cremonini F, Ojetti V, Finizio R, et al. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Am J Gastroenterol 2006; 101: 1985-1990 (Pubitemid 44337620)
14. Gisbert JP, Fernández-Bermejo M, Molina-Infante J, Pérez-Gallardo B, Prieto-Bermejo AB, Mateos-Rodríguez JM, et al. First-line triple therapy with levofloxacin for Helicobacter pylori eradication. Aliment Pharmacol Ther 2007; 26: 495-500. (Pubitemid 47063147)
15. Gisbert JP, Fernández-Bermejo M, Molina-Infante M, Pérez-Gallardo B, Prieto-Bermejo AB, Mateos-Rodríguez JM, et al. Levofloxacin, amoxicillin, and omeprazole as first-line triple therapy for Helicobacter pylori eradication. Helicobacter 2008; 13: 460-461
16. Caselli M, Zullo A, Maconi G, Parente F, Alvisi V, Casetti T, et al., for the Working Group of the Cervia II Meeting. "Cervia II Working Group Report 2006": Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 2007; 39: 782-789
17. Chey WD, Wong BCY, and the Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology Guideline on the Management of the Helicobacter pylori Infection. Am J Gastroenterol 2007; 102: 1808-1825
18. Malfertheiner P, Mégraud P, O'Morain C, Bell D, Bianchi Porro G, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997; 9: 1-2.
19. Gisbert JP, González L, Calvet X, García N, López, Roque M, et al. Protom pump inhibitor, clarithromycin an either amoxycillin or nitrimidazole. A meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14: 1319-1328
20. Gisbert JP, Boixeda D, Aller R, de la Serna C, Sanz E, Martín de Argila C, et al. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection, efficacy of three triple therapies and role of eradication in the prevention of recurrent hemorrhage. Med Clin (Barc) 1999; 112: 161-165
21. Calvet X, Ducons J, Bujanda L, Bory F, Montserrat A, Gisbert JP, for the HP Study Group ot the Asociación Española de Gastroenterología. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. Am J Gastroenterol 2005; 100: 1696-1701
22. Boixeda D, Martín de Argila C, Bermejo F, López Sanroman A, Hernández Ranz F, Gracía Plaza A. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triole therapy. Factors that influence Helicobacter pylori eradication success. Rev Esp Enferm Dig 2003; 95: 202-205
23. Gisbert JP, De la Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35-44. (Pubitemid 43381164)
24. Gisbert JP, Bermejo F, Castro-Fernández M, Pérez-Aisa A, Fernández-Bermejo M, Tomas A, et al. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 patients. Am J Gastroenterol 2008; 103: 71-76
25. Gisbert JP, Castro-Fernández M, Bermejo F, Pérez-Aisa, Ducons J, Fernández-Bermejo M, et al. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. Am J Gastroenterol 2006; 101: 243-247 (Pubitemid 43381662)
26. Bogaerts P, Berthin C, Nizet H, Glupczynski Y. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Beligium. Helicobacter 2006; 11: 441-445 (Pubitemid 44352615)
27. Zullo A, Perna F, Hassan C, Ricci C, Saracino I, Morini S, et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007; 25: 1429-1433 (Pubitemid 46848887)
28. Pajares García JM, Pajares-Villarroya R, Gisbert JP. Helicobacter pylori infection: antibiotic resistance. Rev Esp Enferm Dig 2007; 99: 63-70. (Pubitemid 350259865)
29. Wu DC, Hsu PI, Wu JK, Opekun AR, Graham DY. Randomized controlled comparison of sequential and quadruple (concomitant) therapies for H. pylori infection. Gastroenterology 2008; 134 (Supl. I): 137.
30. Sánchez-Delgado J, Calvet X, Bujanda L, Gisbert JP, Titó L, Castro M. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol 2008; 103: 2220-2223